Cargando…
Lower expression of KAI1 as a biomarker of poor survival prognosis of melanoma combined with colorectal cancer metastasis
OBJECTIVE: This study aimed to investigate the correlation between KAI1 (CD82) and miR-633 expression and prognosis and survival time of patients with melanoma combined with colorectal cancer (CRC). METHODS: Clinical and follow-up data of melanoma and CRC patients were recorded, and the expression l...
Autores principales: | Du, Xudong, Wang, Bo, Liu, Lei, Li, Yang, Wang, Zheng-xiang, Zhang, Guang-jing, Yang, Xiu-fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373138/ https://www.ncbi.nlm.nih.gov/pubmed/35942551 http://dx.doi.org/10.1177/03000605221116758 |
Ejemplares similares
-
Expression of the Metastasis Suppressor KAI1 in Uveal Melanoma
por: Maloney, Shawn C., et al.
Publicado: (2013) -
Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis
por: Zhang, Guohong, et al.
Publicado: (2015) -
Analysis of the postoperative hemostatic profile of colorectal cancer patients subjected to liver metastasis resection surgery
por: Perez Navarro, Guillermo, et al.
Publicado: (2019) -
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma
por: Zhu, Bo, et al.
Publicado: (2017) -
Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival
por: Cantero-Cid, Ramón, et al.
Publicado: (2022)